{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-22-027006","form_type":"8-K","ticker":"TERN","cik":"0001831363","company_name":"Terns Pharmaceuticals, Inc.","filed_at":"2022-12-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:52.499196+00:00","generated_at":"2026-06-20T23:32:27.467854+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Terns Pharmaceuticals prices $75M public offering of 10.35M shares at $7.25","bullets":["Underwritten offering of 10,350,000 shares at $7.25 per share; gross proceeds ~$75M.","Underwriters' option for 1,552,500 additional shares exercised in full; net proceeds ~$80.8M.","Proceeds to advance TERN-501, TERN-701, and TERN-601 clinical programs and for working capital.","Lead book-runners: Jefferies and Cowen; co-managers: UBS, Mizuho, JMP Securities.","Offering priced Dec 20, 2022; closed Dec 23, 2022."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-22-027006","json":"https://secwatch.observer/filing/0000950170-22-027006.json","markdown":"https://secwatch.observer/filing/0000950170-22-027006.md","text":"https://secwatch.observer/filing/0000950170-22-027006.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1831363/000095017022027006/0000950170-22-027006-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1831363/000095017022027006/tern-20221220.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T23:32:27.467854+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}